OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in covalent drug discovery
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 469
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 469
Showing 26-50 of 469 citing articles:
Reversible Dual-Covalent Molecular Locking of the 14-3-3/ERRγ Protein–Protein Interaction as a Molecular Glue Drug Discovery Approach
B. Somsen, Rick J.C. Schellekens, Carlo J. A. Verhoef, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 12, pp. 6741-6752
Open Access | Times Cited: 24
B. Somsen, Rick J.C. Schellekens, Carlo J. A. Verhoef, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 12, pp. 6741-6752
Open Access | Times Cited: 24
The importance of binding kinetics and drug–target residence time in pharmacology
Kevin E. Knockenhauer, Robert A. Copeland
British Journal of Pharmacology (2023) Vol. 181, Iss. 21, pp. 4103-4116
Closed Access | Times Cited: 24
Kevin E. Knockenhauer, Robert A. Copeland
British Journal of Pharmacology (2023) Vol. 181, Iss. 21, pp. 4103-4116
Closed Access | Times Cited: 24
An Analysis of Successful Hit-to-Clinical Candidate Pairs
Dean G. Brown
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7101-7139
Closed Access | Times Cited: 24
Dean G. Brown
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7101-7139
Closed Access | Times Cited: 24
Development of covalent inhibitors: Principle, design, and application in cancer
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 24
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 24
Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input
Ka Yang, Rebecca L. Whitehouse, S L Dawson, et al.
Cell chemical biology (2023) Vol. 31, Iss. 3, pp. 565-576.e4
Closed Access | Times Cited: 24
Ka Yang, Rebecca L. Whitehouse, S L Dawson, et al.
Cell chemical biology (2023) Vol. 31, Iss. 3, pp. 565-576.e4
Closed Access | Times Cited: 24
Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments
Arron Aatkar, Aini Vuorinen, Oliver Longfield, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 9, pp. 1926-1937
Open Access | Times Cited: 23
Arron Aatkar, Aini Vuorinen, Oliver Longfield, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 9, pp. 1926-1937
Open Access | Times Cited: 23
Organic‐Platinum Hybrids for Covalent Binding of G‐Quadruplexes: Structural Basis and Application to Cancer Immunotherapy
Liu‐Yi Liu, Tianzhu Ma, You‐Liang Zeng, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 36
Closed Access | Times Cited: 23
Liu‐Yi Liu, Tianzhu Ma, You‐Liang Zeng, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 36
Closed Access | Times Cited: 23
Large library docking for novel SARS‐CoV ‐2 main protease non‐covalent and covalent inhibitors
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 22
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 22
Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3σ/ERα Protein–Protein Interaction from Nonselective Fragments
Markella Konstantinidou, Emira J. Visser, Edmee Vandenboorn, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20328-20343
Open Access | Times Cited: 22
Markella Konstantinidou, Emira J. Visser, Edmee Vandenboorn, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20328-20343
Open Access | Times Cited: 22
A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer
Anni Hu, Hang Wang, Qianqian Xu, et al.
Redox Biology (2023) Vol. 68, pp. 102959-102959
Open Access | Times Cited: 22
Anni Hu, Hang Wang, Qianqian Xu, et al.
Redox Biology (2023) Vol. 68, pp. 102959-102959
Open Access | Times Cited: 22
Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development
Guanghui Tang, Wei Wang, Chengjun Zhu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 14
Guanghui Tang, Wei Wang, Chengjun Zhu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 14
The role of the methoxy group in approved drugs
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 14
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 14
Template-assisted covalent modification underlies activity of covalent molecular glues
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 14
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 14
NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation
Xueqin Jiang, Xinlu Zhang, Xiaoying Cai, et al.
Science Advances (2024) Vol. 10, Iss. 6
Open Access | Times Cited: 11
Xueqin Jiang, Xinlu Zhang, Xiaoying Cai, et al.
Science Advances (2024) Vol. 10, Iss. 6
Open Access | Times Cited: 11
Demystifying Functional Parameters for Irreversible Enzyme Inhibitors
David E. Heppner, Blessing C. Ogboo, Daniel A. Urul, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14693-14696
Closed Access | Times Cited: 11
David E. Heppner, Blessing C. Ogboo, Daniel A. Urul, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14693-14696
Closed Access | Times Cited: 11
Photoaffinity labelling with small molecules
Rick A. Homan, John D. Lapek, Christina M. Woo, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 10
Rick A. Homan, John D. Lapek, Christina M. Woo, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 10
Accurate prediction of protein function using statistics-informed graph networks
Yaan J. Jang, Qi-Qi Qin, Siyu Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Yaan J. Jang, Qi-Qi Qin, Siyu Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells
Evert Njomen, Rachel E. Hayward, Kristen E. DeMeester, et al.
Nature Chemistry (2024) Vol. 16, Iss. 10, pp. 1592-1604
Closed Access | Times Cited: 10
Evert Njomen, Rachel E. Hayward, Kristen E. DeMeester, et al.
Nature Chemistry (2024) Vol. 16, Iss. 10, pp. 1592-1604
Closed Access | Times Cited: 10
Recent advances in self‐immobilizing fluorescent probes for in vivo imaging
Yong Zhang, Xuemei Lv, Yafu Wang, et al.
Smart Molecules (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 10
Yong Zhang, Xuemei Lv, Yafu Wang, et al.
Smart Molecules (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 10
Increasing the Throughput and Reproducibility of Activity-Based Proteome Profiling Studies with Hyperplexing and Intelligent Data Acquisition
Hanna G. Budayeva, P. Taylur, Shuai Wang, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 2934-2947
Open Access | Times Cited: 9
Hanna G. Budayeva, P. Taylur, Shuai Wang, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 2934-2947
Open Access | Times Cited: 9
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution
Yufeng Xiao, Yaxia Yuan, Yi Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 8
Yufeng Xiao, Yaxia Yuan, Yi Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 8
Proteomics: An In‐Depth Review on Recent Technical Advances and Their Applications in Biomedicine
Jing Liang, Jun Tian, Huadong Zhang, et al.
Medicinal Research Reviews (2025)
Closed Access | Times Cited: 1
Jing Liang, Jun Tian, Huadong Zhang, et al.
Medicinal Research Reviews (2025)
Closed Access | Times Cited: 1
Target Discovery Driven by Chemical Biology and Computational Biology
B J Lyu, Wenfeng Gou, Feifei Xu, et al.
The Chemical Record (2025)
Closed Access | Times Cited: 1
B J Lyu, Wenfeng Gou, Feifei Xu, et al.
The Chemical Record (2025)
Closed Access | Times Cited: 1
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer
Ramona Rudalska, Jule Harbig, Michael Förster, et al.
Nature Cancer (2025)
Open Access | Times Cited: 1
Ramona Rudalska, Jule Harbig, Michael Förster, et al.
Nature Cancer (2025)
Open Access | Times Cited: 1
